Name: | Indinavir |
---|---|
PubChem Compound ID: | 11954281 |
Description: | A potent and specific HIV protease inhibitor that appears to have good oral bioavailability. |
Molecular formula: | C38H55N5O9S |
Molecular weight: | 757.938 g/mol |
Synonyms: |
Indinavir sulfate ethanolate (JAN); Indinavir sulfate ethanolate; Crixivan; D02861; Crixivan (TN)
|
Name: | Indinavir |
---|---|
Name (isomeric): | DB00224 |
Drug Type: | small molecule |
Description: | A potent and specific HIV protease inhibitor that appears to have good oral bioavailability. |
Synonyms: |
Compound J; Indinavir sulfate
|
Brand: | Crixivan |
Category: | HIV Protease Inhibitors, Anti-HIV Agents |
CAS number: | 150378-17-9 |
Indication: | Indinavir is an antiretroviral drug for the treatment of HIV infection. |
---|---|
Pharmacology: |
Indinavir is a protease inhibitor with activity against Human Immunodeficiency Virus Type 1 (HIV-1). Protease inhibitors block the part of HIV called protease. HIV-1 protease is an enzyme required for the proteolytic cleavage of the viral polyprotein precursors into the individual functional proteins found in infectious HIV-1. Indinavir binds to th...
show more » |
Mechanism of Action: | Indinavir inhibits the HIV viral protease enzyme which prevents cleavage of the gag-pol polyprotein, resulting in noninfectious, immature viral particles. |
Absorption: | Rapidly absorbed |
Protein binding: | 60% |
Biotransformation: | Hepatic. Seven metabolites have been identified, one glucuronide conjugate and six oxidative metabolites. In vitro studies indicate that cytochrome P-450 3A4 (CYP3A4) is the major enzyme responsible for formation of the oxidative metabolites. |
Route of elimination: | Less than 20% of indinavir is excreted unchanged in the urine. |
Half Life: | 1.8 (± 0.4) hours |
Toxicity: | Symptoms of overdose include myocardial infarction and angina pectoris. |
Affected organisms: | Human Immunodeficiency Virus |
Food interaction: |
| ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Drug interaction: |
|